Login / Signup

System analysis based on the cancer-immunity cycle identifies ZNF207 as a novel immunotherapy target for hepatocellular carcinoma.

Xu WangTao ZhouXingyi ChenYu WangYushi DingHaoyang TuShengyang GaoHaoyu WangXinying TangYong Yang
Published in: Journal for immunotherapy of cancer (2022)
Our study implicates ZNF207 in suppressing the HCC microenvironment and showed the feasibility of targeting ZNF207 during anti-PD1 therapy in HCC.
Keyphrases
  • papillary thyroid
  • stem cells
  • signaling pathway
  • squamous cell
  • genome wide
  • gene expression
  • mesenchymal stem cells
  • bone marrow
  • smoking cessation
  • data analysis